Latest Operating Expenses News

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.

Lake Resources N.L. has released a pivotal DFS Addendum for its Kachi lithium project, showcasing enhanced lithium grades, reduced costs, and robust financial metrics that position the project as a leading lithium brine development in Argentina.

FBR Limited has secured a significant $7.8 million memorandum of understanding for its Hadrian X® robotic bricklayer and launched a new DST®-enabled welding robot, Mantis, while advancing automation projects with Samsung Heavy Industries.

Pure Foods Tasmania reports solid progress in its turnaround strategy with significant cost reductions and improved product quality, setting the stage for profitable growth in FY26.

Equity Story Group has secured a transformative deal to acquire Baker Young Limited, significantly expanding its wealth advisory footprint and boosting revenue projections by over 400%. Meanwhile, its Growth Fund outperforms benchmarks and a new litigation funding vehicle launches.

Jayride Group has launched a new SaaS platform aimed at transforming its business model from a traditional aggregator to a scalable, subscription-based technology provider for ground transportation. Early integrations in Southeast Asia signal a strategic shift with promising growth potential.

FortifAI Limited reports steady revenue, significant cost reductions, and a strengthened balance sheet with $3 million cash and no debt. The company advances its AI Lab initiative while expanding its project pipeline and board expertise.

RocketBoots Limited has expanded its sales pipeline with five new customers covering over 8,550 locations and secured a strategic $1 million investment from Bombora Funds, positioning itself strongly in the growing AI retail technology market.

Cyprium Metals has made significant strides in its phased restart of the Nifty Copper Complex, targeting a final investment decision in Q3 2025, while consolidating 100% ownership of the Paterson Exploration Project after IGO's exit.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.

High Peak Royalties Limited reported stable royalty receipts of A$345,240 for the June 2025 quarter, maintaining cash flow while advancing monitoring of key gas and geothermal assets across Australia and the US.

Sportshero Ltd’s latest quarterly cash flow report reveals ongoing operational cash outflows balanced by financing activities, leaving the company with just over two quarters of funding runway.